Argitalpenak (21) Ikertzaileren baten partaidetza izan duten argitalpenak

2002

  1. A propósito de un caso: Linfoma anaplásico en un paciente con lupus eritematoso sistémico

    Oncologia, Vol. 25, Núm. 6, pp. 64-67

  2. Assessing the use of p16INK4a promoter gene methylation in serum for detection of bladder cancer

    European Urology, Vol. 42, Núm. 6, pp. 622-630

  3. Ball-and-socket ankle joint with hypoplastic sustentaculum tali

    European Radiology, Vol. 12, Núm. SUPPL. 3

  4. Breast cancer acute radiotherapy morbidity evaluated by different scoring systems

    Breast Cancer Research and Treatment, Vol. 73, Núm. 2, pp. 127-134

  5. Cervical spondylolysis. Two case reports

    Radiologia, Vol. 44, Núm. 7, pp. 305-307

  6. Determination of endocrine-disrupting pesticides and polychlorinated biphenyls in human serum by GC-ECD and GC-MS-MS and evaluation of contributions to the uncertainty of the results

    Analytical and Bioanalytical Chemistry, Vol. 372, Núm. 7-8, pp. 766-775

  7. Dual effects of phytoestrogens result in U-shaped dose-response curves

    Environmental Health Perspectives, Vol. 110, Núm. 8, pp. 743-748

  8. Endocrine disrupting chemicals: harmful substances and how to test them.

    Cadernos de saúde pública / Ministério da Saúde, Fundação Oswaldo Cruz, Escola Nacional de Saúde Pública, Vol. 18, Núm. 2, pp. 489-494

  9. Estrogenic effect of a series of bisphenol analogues on gene and protein expression in MCF-7 breast cancer cells

    Journal of Steroid Biochemistry and Molecular Biology, Vol. 82, Núm. 1, pp. 45-53

  10. Estudio por imagen del seudotumor hemofílico

    Radiologia, Vol. 44, Núm. 5, pp. 220-223

  11. Human exposure to endocrine disrupters, an overview

    ENDOCRINE DISRUPTERS AND CARCINOGENIC RISK ASSESSMENT

  12. Individualisation of radiotherapy in breast cancer patients: Possible usefulness of a DNA damage assay to measure normal cell radiosensitivity

    Radiotherapy and Oncology, Vol. 62, Núm. 3, pp. 327-333

  13. Interactions between radiotherapy and endocrine therapy in breast cancer

    Endocrine-Related Cancer, Vol. 9, Núm. 3, pp. 197-205

  14. Is mammographic screening justified?

    Radiologia, Vol. 44, Núm. 2, pp. 61-64

  15. Las talasemias y sus implicaciones odontológicas

    Medicina oral, Vol. 7, Núm. 1, pp. 36-45

  16. Las talasemias y sus implicaciones odontológicas

    Medicina Oral, Vol. 7, Núm. 1, pp. 36-45

  17. Mammographic screening [2] (multiple letters)

    Radiologia

  18. Manual práctico de radiología odontológica

    Granada (Avda. Divina Pastora, 9, 18200 Granada) : J. de D. López-González, 2002

  19. PARP-1 modifies the effectiveness of p53-mediated DNA damage response

    Oncogene, Vol. 21, Núm. 7, pp. 1108-1116

  20. Perspectives on endocrine disruption

    Gaceta sanitaria / S.E.S.P.A.S, Vol. 16, Núm. 3, pp. 250-256